# Janux Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Mar 10, 2025

- Company: [Janux Therapeutics, Inc.](/companies/janx.md) (CIK 1817713)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-10
- Accepted by EDGAR: Mar 10, 2025, 16:33 ET
- Period: not reported
- Accession: 0001415889-25-007529
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1817713/000141588925007529/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1817713/000141588925007529/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1817713/000141588925007529/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 10, 2025.
Source: SEC EDGAR, the filing index for accession 0001415889-25-007529. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.